Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells

Cancer Research

Volumn 63, Issue 2, 2003, Pages 282-286

  Ginn Pease, Margaret E ^a,b   Eng, Charis ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL STRAIN MCF 7; CHROMOSOME 10; CONTROLLED STUDY; FLUOROSCOPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

BREAST NEOPLASMS; CELL NUCLEUS; CYTOPLASM; G0 PHASE; G1 PHASE; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0037439684     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Wash. DC), 275: 1943-1947, 1997.
2. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H., and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
3. Vazquez, F., and Sellers, W. R. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim. Biophys. Acta. 1470: M21-M35, 2000.
4. Gimm, O., Perren, A., Weng, L. P., Marsh, D. J., Yeh, J. J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J. A., Mutter, G. L., Robinson, B. G., Komminoth, P., Dralle, H., and Eng, C. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue and benign and malignant epithelial thyroid tumors. Am. J. Pathol., 156: 1693-1700, 2000.
5. Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., and Eng, C. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am. J. Pathol., 157: 1097-1103, 2000.
6. Whiteman, D. C., Zhou, X. P., Cummings, M. C., Pavey, S., Hayward, N. K., and Eng, C. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int. J. Cancer, 99: 63-67, 2002.
7. Tachibana, M., Shibakita, M., Ohno, S., Kinugasa, S., Yoshimura, H., Ueda, S., Fujii, T., Rahman, M. A., Dhar, D. K., and Nagasue, N. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer (Phila.), 94: 1955-1960, 2002.
8. Zhou, X. P., Kuismanen, S., Nystrom-Lahti, M., Peltomaki, P., and Eng, C. Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors. Hum. Mol. Genet., 11: 445-450, 2002.
9. Lachyankar, M. B., Sultana, N., Schonhoff, C. M., Mitra, P., Poluha, W., Lambert, S., Quesenberry, P. J., Litofsky, N. S., Recht, L. D., Nabi, R., Miller, S. J., Ohta, S., Neel, B. G., and Ross, A. H. A role for nuclear PTEN in neuronal differentiation. J. Neurosci., 20: 1404-1413, 2000.
10. Li, L., Ernsting, B. R., Wishart, M. J., Lohse, D. L., and Dixon, J. E. A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J. Biol. Chem., 272: 29403-29406, 1997.
11. Hlobilkova, A., Guldberg, P., Thullberg, M., Zeuthen, J., Lukas, J., and Bartek, J. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Exp. Cell Res., 256: 571-577, 2000.
12. 1 arrest followed by cell death. Cancer Res., 59: 5808-5814, 1999.
13. 1 cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res., 61: 4569-4575, 2001.
14. Davezac, N., Baldin, V., Gabrielli, B., Forrest, A., Theis-Febvre, N., Yashida, M., and Ducommun, B. Regulation of CDC25B phosphatases subcellular localization. Oncogene, 19: 2179-2185, 2000.
15. Yamada, K. M., and Araki, M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell Sci., 114: 2375-2382, 2001.
16. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K. M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science (Wash. DC), 280: 1614-1617, 1998.
17. Yu, Z., Fotouhi-Aroakani, N., Wu, L., Maoui, M., Wang, S., Banville, D., and Shen, S. H. PTEN associates with the vault particles in HeLa cells. J. Biol. Chem., 277: 40247-40252, 2002.
18. Furnari, F. B., Lin, H., Huang, H. S., and Cavenee, W. K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA, 94: 12479-12484, 1997.
19. Mayo, L. D., Dixon, J. E., Durden, D. L., Tonks, N. K., and Donner, D. B. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem., 277: 5484-5489, 2002.
20. Liang, S. H., and Clarke, M. F. A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboyl-terminal domain. J. Biol. Chem., 274: 32699-32703, 1999.